Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.92 USD
−3.85 M USD
79.18 M USD
10.04 M
About Journey Medical Corporation
Sector
CEO
Claude Maraoui
Headquarters
Scottsdale
Website
Founded
2014
FIGI
BBG00ZWVDRK2
Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of DERM is 5.37 USD — it has increased by 3.27% in the past 24 hours. Watch Journey Medical Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Journey Medical Corporation stocks are traded under the ticker DERM.
DERM stock has risen by 5.09% compared to the previous week, the month change is a −12.82% fall, over the last year Journey Medical Corporation has showed a 21.22% increase.
We've gathered analysts' opinions on Journey Medical Corporation future price: according to them, DERM price has a max estimate of 11.00 USD and a min estimate of 9.00 USD. Watch DERM chart and read a more detailed Journey Medical Corporation stock forecast: see what analysts think of Journey Medical Corporation and suggest that you do with its stocks.
DERM reached its all-time high on Nov 12, 2021 with the price of 10.20 USD, and its all-time low was 1.02 USD and was reached on May 18, 2023. View more price dynamics on DERM chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
DERM stock is 10.51% volatile and has beta coefficient of 0.91. Track Journey Medical Corporation stock price on the chart and check out the list of the most volatile stocks — is Journey Medical Corporation there?
Today Journey Medical Corporation has the market capitalization of 111.31 M, it has increased by 0.78% over the last week.
Yes, you can track Journey Medical Corporation financials in yearly and quarterly reports right on TradingView.
Journey Medical Corporation is going to release the next earnings report on Mar 20, 2025. Keep track of upcoming events with our Earnings Calendar.
DERM earnings for the last quarter are −0.12 USD per share, whereas the estimation was −0.17 USD resulting in a 29.41% surprise. The estimated earnings for the next quarter are −0.20 USD per share. See more details about Journey Medical Corporation earnings.
Journey Medical Corporation revenue for the last quarter amounts to 14.63 M USD, despite the estimated figure of 14.39 M USD. In the next quarter, revenue is expected to reach 14.01 M USD.
DERM net income for the last quarter is −2.39 M USD, while the quarter before that showed −3.36 M USD of net income which accounts for 28.89% change. Track more Journey Medical Corporation financial stats to get the full picture.
No, DERM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 25, 2024, the company has 58.00 employees. See our rating of the largest employees — is Journey Medical Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Journey Medical Corporation EBITDA is −14.66 M USD, and current EBITDA margin is 6.22%. See more stats in Journey Medical Corporation financial statements.
Like other stocks, DERM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Journey Medical Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Journey Medical Corporation technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Journey Medical Corporation stock shows the buy signal. See more of Journey Medical Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.